Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Penumbra Class I Recall Again Raises Concerns About 510(k) Pathway, Device Creep

Dec 09 2021

Facade at headquarters of pharmaceutical and medical device manufacturing company Penumbra on Bay Farm Island, Alameda, California

Related Content

Class I Recall On Penumbra Catheter After Death, Injury Reports

Dec 17 2020

US FDA Proposes Independent Contractor To Track User Fee Dollars Used To Pay FTEs

Dec 07 2021

FDA Official: Uptick In PMA, 510(k) Applications Calls For More User Fee Dollars

Dec 02 2021

Additional Topics

United States Regulation Policy Compliance Clinical Trials FDA Review Pathway Risk Management Safety Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window